China Pharma (NYSE:CPHI) Now Covered by Analysts at StockNews.com

StockNews.com initiated coverage on shares of China Pharma (NYSE:CPHI) in a research report report published on Wednesday. The brokerage issued a hold rating on the stock.

China Pharma Stock Down 0.4 %

China Pharma stock opened at $0.21 on Wednesday. The company has a debt-to-equity ratio of 0.22, a current ratio of 0.79 and a quick ratio of 0.26. The firm has a 50-day moving average price of $0.21 and a two-hundred day moving average price of $0.21. China Pharma has a 52-week low of $0.13 and a 52-week high of $0.44.

China Pharma Company Profile

China Pharma Holdings, Inc develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products to hospitals and private retailers in the People’s Republic of China. The company provides products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions.